With an increasing number of low-solubility drugs emerging as new drug candidates, enabling technologies that improve aqueous solubility are in high demand. This webinar explores an attractive option with a proven track record in solubility enhancement: amorphous solid dispersions prepared by hot-melt extrusion (HME) technology. HME technology offers a number of advantages, including low capital and manufacturing costs, a small equipment footprint, and a continuous process scheme. This webinar reviews the requirements for HME formulations, compares HME products to amorphous dispersions produced by spray-drying, and provides an overview of the HME process, including equipment components and process variables.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.